Envestnet Asset Management’s F-star Therapeutics FSTX Stock Holding History
Bought
Maintained
Sold
Envestnet Asset Management's FSTX Position: Q1 2023 in Review
Envestnet Asset Management sold out of F-star Therapeutics (FSTX) in Q1 2023, closing a stake of 11,067 shares — an estimated $69.9K sold.
Envestnet Asset Management first reported a position in FSTX in Q1 2022 and held it in 4 quarters. The position peaked at $90K in Q2 2022. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.
- Envestnet Asset Management reported no remaining F-star Therapeutics position as of Q1 2023 after selling out during the quarter.
- Envestnet Asset Management sold 11,067 F-star Therapeutics shares in Q1 2023, an estimated $69.9K.
- Envestnet Asset Management first reported a position in F-star Therapeutics in Q1 2022 and held it in 4 quarters.
- Envestnet Asset Management's F-star Therapeutics position peaked at $90K in Q2 2022.
- 0 funds tracked by Wall St. Rank held F-star Therapeutics as of Q1 2023.
Based on Envestnet Asset Management's 13F filing for Q1 2023, filed 11 May 2023.